Westerville, Ohio — Hundreds of students at Otterbein University received the one-time shot of the Johnson & Johnson COVID-19 vaccine. Now, there’s cause for concern as Gov. Mike DeWine pushed the pause button on its distribution.
What You Need To Know
- Students said research after news about the Johnson & Johnson vaccine has calmed their fears
- Peer pressure to get the vaccine is now a thought in the minds of students who experienced side effects
- Otterbein University is still surveying students to see if they want a COVID-19 vaccine
- Students who have been vaccinated can opt out of the asymptomatic testing on campus
Otterbein officials said it received 2,400 doses of the vaccine, but only distributed 700.
Most of the early-on side effects ranged from headaches, sore arms and fevers.
Harold Walston’s symptoms went beyond that. He had body aches, chills and vomiting after getting the vaccine. He became more concerned when he learned six women got blood clots after getting the vaccine.
That’s when he decided to do his own research about blood clots. He explained that doing the research calmed him down.
Yet, his biggest concern was for his mom and brother who also received the Johnson & Johnson vaccine. While talking to his mom, he said they created a vaccine reaction plan just in case something happened to one of them.
While he doesn’t regret getting vaccinated, he is hoping his family will stay safe.
Otterbein’s semester ends in three weeks. Students who received the Johnson & Johnson vaccine are being encouraged to see their primary care physician or someone in the health center on campus.
As for any remaining doses of the vaccine, it will not be distributed. Students who still want a vaccine are being redirected to other sites that may have the Moderna or Pfizer vaccine.
